Search Results - "Kuhn, Chantal"
-
1
Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside
Published in Immunotherapy (01-07-2016)“…The induction of tolerance is a major goal of immunotherapy. Investigations over the last 20 years have shown that anti-CD3 monoclonal antibodies (mAbs)…”
Get full text
Journal Article -
2
MicroRNA-146a limits tumorigenic inflammation in colorectal cancer
Published in Nature communications (23-04-2021)“…Chronic inflammation can drive tumor development. Here, we have identified microRNA-146a (miR-146a) as a major negative regulator of colonic inflammation and…”
Get full text
Journal Article -
3
Smad7 Controls Immunoregulatory PDL2/1-PD1 Signaling in Intestinal Inflammation and Autoimmunity
Published in Cell reports (Cambridge) (24-09-2019)“…Smad7, a negative regulator of TGF-β signaling, has been implicated in the pathogenesis and treatment of inflammatory bowel diseases (IBDs), including Crohn's…”
Get full text
Journal Article -
4
γδ T cells control humoral immune response by inducing T follicular helper cell differentiation
Published in Nature communications (08-08-2018)“…γδ T cells have many known functions, including the regulation of antibody responses. However, how γδ T cells control humoral immunity remains elusive. Here we…”
Get full text
Journal Article -
5
Gamma-delta T cells modulate the microbiota and fecal micro-RNAs to maintain mucosal tolerance
Published in Microbiome (23-02-2023)“…Gamma-delta (γδ) T cells are a major cell population in the intestinal mucosa and are key mediators of mucosal tolerance and microbiota composition. Little is…”
Get full text
Journal Article -
6
Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetes
Published in PloS one (24-10-2013)“…In the present study, we investigated the therapeutic potential of a selective S1P1 receptor modulator, ponesimod, to protect and reverse autoimmune diabetes…”
Get full text
Journal Article -
7
Human CD3 transgenic mice: preclinical testing of antibodies promoting immune tolerance
Published in Science translational medicine (02-02-2011)“…Monoclonal antibodies have proven to be potent agents to promote immunological tolerance in animal models of autoimmune disease and transplantation. However,…”
Get more information
Journal Article -
8
Immune response to human embryonic stem cell‐derived cardiac progenitors and adipose‐derived stromal cells
Published in Journal of cellular and molecular medicine (01-07-2012)“…Transplantation of allogeneic human embryonic stem cell‐derived cardiac progenitors triggers an immune response. We assessed whether this response could be…”
Get full text
Journal Article -
9
-
10
Boosting the career development of postdocs with a peer-to-peer mentor circles program
Published in Nature biotechnology (12-07-2016)“…Mentor circles combine the advantages of both mentoring networks and peer-to-peer mentoring…”
Get full text
Journal Article -
11
IL-6R signaling inhibits generation of Th3 cells and is a promising therapeutic target for enhancing oral tolerance induction
Published in The Journal of immunology (1950) (01-05-2016)“…Abstract Oral antigen administration results in systemic hyporesponsiveness to a subsequent challenge with the fed antigen (oral tolerance) and has been shown…”
Get full text
Journal Article -
12
Immunology. How does the immune system tolerate food?
Published in Science (American Association for the Advancement of Science) (19-02-2016)Get full text
Journal Article -
13
How does the immune system tolerate food?
Published in Science (American Association for the Advancement of Science) (19-02-2016)“…Intestinal T cells balance the immune response to microbes and food [Also see Report by Kim et al. ] The gastrointestinal immune system (gut-associated…”
Get full text
Journal Article -
14
IL-6 Inhibits Upregulation of Membrane-Bound TGF-β 1 on CD4+ T Cells and Blocking IL-6 Enhances Oral Tolerance
Published in The Journal of immunology (1950) (01-02-2017)“…Oral administration of Ag induces regulatory T cells that express latent membrane-bound TGF-β (latency-associated peptide [LAP]) and have been shown to play an…”
Get full text
Journal Article -
15
γδ T Cell-Secreted XCL1 Mediates Anti-CD3-Induced Oral Tolerance
Published in The Journal of immunology (1950) (15-11-2019)“…Oral tolerance is defined as the specific suppression of cellular and/or humoral immune responses to an Ag by prior administration of the Ag through the oral…”
Get full text
Journal Article -
16
Regulatory mechanisms of immune tolerance in type 1 diabetes and their failures
Published in Journal of autoimmunity (01-07-2016)“…Abstract In this brief review we propose to discuss salient data showing the importance of immune regulatory mechanisms, and in particular of Treg, for the…”
Get full text
Journal Article -
17
Oral treatment with foralumab, a fully human anti-CD3 monoclonal antibody, prevents skin xenograft rejection in humanized mice
Published in Clinical immunology (Orlando, Fla.) (01-10-2017)“…Oral administration of biologics may be a feasible approach for immune therapy that improves drug safety and potentiates mechanisms of tolerance at mucosal…”
Get full text
Journal Article -
18
Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain
Published in Journal of autoimmunity (01-01-2017)“…Abstract CD3-specific monoclonal antibody (mAb) treats autoimmune disease in animal models and has shown promise in clinical trials of type 1 diabetes. Whereas…”
Get full text
Journal Article -
19
Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptance
Published in The Journal of immunology (1950) (01-11-2014)“…Cell therapy and the use of mAbs that interfere with T cell effector functions constitute promising approaches for the control of allograft rejection. In the…”
Get full text
Journal Article -
20
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models
Published in Journal for immunotherapy of cancer (01-05-2022)“…Despite promising clinical results in a small subset of malignancies, therapies based on engineered chimeric antigen receptor and T-cell receptor T cells are…”
Get full text
Journal Article